Finance

Lists
3164:TPE
GenMont Biotech Inc
NT$16,55
-0,30%
(-0,050) 1D
11 Aug., 13:30:06 GMT+8  ·   TWD
All symbols
SymbolPriceChange% Change
Generating top insights for 3164...
Open
NT$16,45
High
NT$16,55
Low
NT$16,30
Mkt. cap
1,42 mjd
Avg. vol.
34,90 k
Volume
16,52 k
Dividend
4,83%
Quarterly dividend
NT$0,20
Ex-dividend date
08 Apr. 2026
P/E ratio
31,83
52-wk high
NT$20,45
52-wk low
NT$15,90
EPS
NT$0,52
Shares outstanding
88,91 m
No. of employees
147
Open
NT$16,45
High
NT$16,55
Low
NT$16,30
Mkt. cap
1,42 mjd
Avg. vol.
34,90 k
Volume
16,52 k
Dividend
4,83%
Quarterly dividend
NT$0,20
Ex-dividend date
08 Apr. 2026
P/E ratio
31,83
52-wk high
NT$20,45
52-wk low
NT$15,90
EPS
NT$0,52
Shares outstanding
88,91 m
No. of employees
147
About GenMont Biotech Inc
CEO-
Employees147
Founded2000
Headquarters-
Sector-
Previous reportsAll values in TWD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in TWD
Jun. 2025
Sep. 2025
Des. 2025
Mrt. 2026
Revenue
112,17 m
88,90 m
100,70 m
89,17 m
Cost of goods sold
41,30 m
33,41 m
38,03 m
40,95 m
Cost of revenue
41,30 m
33,41 m
38,03 m
40,95 m
Research and development expenses
10,93 m
11,02 m
11,62 m
10,48 m
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
34,68 m
37,01 m
38,04 m
35,28 m
Operating expense
43,32 m
46,77 m
50,91 m
55,40 m
Total operating expenses
84,62 m
80,18 m
88,94 m
96,35 m
Operating income
27,56 m
8,72 m
11,76 m
-7,18 m
Other non operating income
164,00 k
586,00 k
374,00 k
61,00 k
EBT including unusual items
-12,96 m
28,68 m
29,47 m
3,38 m
EBT excluding unusual items
-12,04 m
23,39 m
29,47 m
3,38 m
Income tax expense
-2,15 m
6,38 m
7,16 m
1,58 m
Effective tax rate
16,62%
22,26%
24,31%
46,60%
Other operating expenses
-
-
-
-
Net income
-8,74 m
24,68 m
24,80 m
4,15 m
Net profit margin
-7,79%
27,76%
24,62%
4,65%
Earnings per share
-
-
-
-
Interest and investment income
1,58 m
1,74 m
1,55 m
1,62 m
Interest expense
-977,00 k
-953,00 k
-900,00 k
-937,00 k
Net interest expenses
605,00 k
784,00 k
651,00 k
685,00 k
Depreciation and amortization charges
-
-
-
-
EBITDA
43,11 m
24,07 m
27,26 m
9,11 m
Gain or loss from assets sale
-
-
1,00 k
-
AI content may include mistakes. Learn more

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Create a portfolio
Create a task
Deep Search
AI content may include mistakes. Learn more
Google-programme